Cardiology

Evinacumab cuts cholesterol levels by half in patients with HoFH

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled ...

Diabetes

Hypoglycaemia prevention could cut hospital stays

Preventing in-patients with diabetes from developing hypoglycaemia could dramatically reduce the length of time they spend in hospital—according to new research from the University of East Anglia and Cambridge University ...

page 1 from 7